• Vaccines

Imovax Generic Name & Formulations

General Description

Rabies vaccine 2.5Units/mL; grown in human diploid cell cultures (inactivated whole virus); inj.

How Supplied

Single-dose vial (1mL)—1 (w. syringe and diluent)


Imovax Indications


Preexposure immunization and postexposure treatment of rabies.

Imovax Dosage and Administration

Adults and Children

Preexposure: 3 inj of 1mL IM each on day 0, 7, and either day 21 or 28. Booster doses: 1mL every 2 yrs (see literature). Postexposure treatment: a 5 dose regimen of 1mL IM given on days 0, 3, 7, 14, 28 or 30 (WHO or ACIP recommendations), and 90 (give 1st dose with rabies immune globulin). If previously immunized against rabies, only 2 doses are given, immediately after exposure, and 3 days later (no rabies immune globulin needed).

Imovax Contraindications

Not Applicable

Imovax Boxed Warnings

Not Applicable

Imovax Warnings/Precautions


Postpone preexposure immunization during acute febrile illness or infection. Immunocompromised: may get suboptimal response (monitor titers). Have epinephrine inj (1:1000) available. Pregnancy (Cat.C).

Imovax Pharmacokinetics

See Literature

Imovax Interactions


Immunosuppressants: may get suboptimal response.

Imovax Adverse Reactions

Adverse Reactions

Local reactions (pain, erythema, swelling), systemic reactions (nausea, headache, muscle aches, abdominal pain).

Imovax Clinical Trials

See Literature

Imovax Note

Not Applicable

Imovax Patient Counseling

See Literature